STEVENSON, Md., Aug. 07, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Texas on behalf of purchasers of Applied Optoelectronics, Inc. (Nasdaq:AAOI) (“Applied Optoelectronics” or the “Company”) securities during the period between July 13, 2017 through August 3, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 4, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Applied Optoelectronics securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company’s major customer was reducing its purchases of the Company’s 40G receivers and the loss of this major customer’s business would have a severe negative impact on the Company’s financial performance.
According to the complaint, following an August 3, 2017 press release announcing the financial results for the second quarter of 2017 and stating that there was a softer demand for the 40G receivers, the value of Applied Optoelectronics shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Applied Optoelectronics securities purchased on or after July 13, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



